PROCEPT BioRobotics Corporation
PRCT
$49.96
$1.452.99%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 69.16M | 68.24M | 58.37M | 53.35M | 44.54M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 69.16M | 68.24M | 58.37M | 53.35M | 44.54M |
| Cost of Revenue | 25.00M | 24.56M | 21.46M | 21.87M | 19.51M |
| Gross Profit | 44.16M | 43.67M | 36.91M | 31.48M | 25.03M |
| SG&A Expenses | 55.20M | 48.32M | 42.69M | 40.81M | 39.60M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 96.60M | 87.95M | 80.80M | 80.18M | 72.19M |
| Operating Income | -27.44M | -19.71M | -22.43M | -26.83M | -27.65M |
| Income Before Tax | -24.74M | -18.86M | -20.97M | -25.63M | -25.96M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -24.74M | -18.86M | -20.97M | -25.63M | -25.96M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -24.74M | -18.86M | -20.97M | -25.63M | -25.96M |
| EBIT | -27.44M | -19.71M | -22.43M | -26.83M | -27.65M |
| EBITDA | -25.96M | -18.26M | -21.10M | -25.56M | -26.47M |
| EPS Basic | -0.45 | -0.35 | -0.40 | -0.50 | -0.51 |
| Normalized Basic EPS | -0.28 | -0.22 | -0.25 | -0.31 | -0.32 |
| EPS Diluted | -0.45 | -0.35 | -0.40 | -0.50 | -0.51 |
| Normalized Diluted EPS | -0.28 | -0.22 | -0.25 | -0.31 | -0.32 |
| Average Basic Shares Outstanding | 54.92M | 53.84M | 52.01M | 51.62M | 51.01M |
| Average Diluted Shares Outstanding | 54.92M | 53.84M | 52.01M | 51.62M | 51.01M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |